Phreesia, Inc. (PHR)
Phreesia runs the waiting room. Not the physical one—the digital gateway where patients check in, confirm insurance, give consent, and pay up-front before seeing a doctor. The company builds software that sits at the front desk of healthcare, handling registration, scheduling, payment processing, and patient engagement for over four thousand medical practices and hospital outpatient clinics across the United States. Because it touches nearly one in seven patient visits in America, Phreesia has become an essential piece of the healthcare infrastructure, even if most patients never think twice about who built the iPad they’re using to fill out forms.
Why healthcare practices need a middleman
The inefficiency that Phreesia solves is unglamorous but real. Every time a patient walks into a medical practice, someone has to collect insurance information, update their address, confirm they still have the same medications, and often take a payment up front. Those tasks are manual and repetitive, and they delay the revenue the practice receives. Paper forms pile up in file boxes. Insurance verification happens as an afterthought. Payments trickle in weeks later. The practice loses administrative time and money that could have gone toward patient care.
Phreesia’s software centralizes all of that. Patients check in online before their appointment or on a kiosk in the waiting room. The system verifies insurance coverage against company databases, flags missing information, and secures payment immediately. Once the visit is done, billing data flows straight into the practice’s electronic health record or accounting system. What once took days becomes automatic.
The value proposition is simple: clinics use less staff time and collect more money, faster. For Phreesia, that means recurring subscription fees—a practice pays per month to use the platform—plus a cut of every payment the software processes. That combination of subscription plus transaction revenue is what draws investors, because it means revenue is both predictable and tied to volume.
Scale through integration
What makes Phreesia difficult for competitors to displace is that healthcare workflows are deeply entrenched. Electronic health record systems like Epic, Cerner, and Athenahealth dominate large practices and hospitals. Phreesia does not replace those—it feeds them. The company has spent years building integrations so that data flows seamlessly between its platform and the EHRs clinics already use. Change the EHR and you can use a different intake tool. Change intake software and you suddenly need to re-integrate with your EHR. That friction keeps practices loyal.
The scale of Phreesia’s presence amplifies this advantage. With over four thousand customers handling more than 170 million patient visits per year, the company has become the de facto standard for certain segments. A large hospital system might not switch if it means coordinating integrations with every subsidiary clinic. Insurance companies and pharmaceutical manufacturers have learned that reaching patients through Phreesia’s network is more efficient than building their own channels. That network effect creates a moat: the larger Phreesia grows, the more valuable its platform becomes for both sides.
Two engines: subscriptions and payments
Phreesia’s business has two distinct moving parts. The first is subscription revenue—what practices pay monthly to use the software. That stream is steady and predictable, growing as the company adds new customers and as existing customers add more locations. It carries healthy margins because the software runs on Phreesia’s servers and scales across thousands of practices with minimal extra cost per customer.
The second engine is payment processing. When a patient pays a copay or an out-of-pocket cost through Phreesia’s platform, the company takes a transaction fee. That business grows with the total dollar volume flowing through the platform, but it is also sensitive to how much patients are actually paying out of pocket—a variable that depends on insurance copays, deductibles, and how much practices decide to collect up front.
The third, smaller stream is Network Solutions—advertising and engagement revenue from life sciences companies that want to reach patients. A pharmaceutical manufacturer might pay to place educational content about a condition in front of patients who visit practices using Phreesia’s software. That stream is smaller today but represents a long-term growth lever if healthcare companies increasingly choose digital engagement over traditional marketing.
Growth constraints and the question of saturation
At its core, Phreesia’s growth is capped by the number of healthcare practices in America. The company estimates its addressable market at roughly fifty thousand provider organizations. With over four thousand customers signed up, Phreesia has captured perhaps a tenth of its potential market, which suggests runway for growth. But that calculation assumes the market is not shrinking. Consolidation is real in healthcare—smaller practices merge into larger hospital systems, and those systems have more power to negotiate software contracts. A ten-location practice might pay Phreesia a few thousand dollars a month. A three-hundred-location hospital system negotiates a much better rate per location.
The shift from independent to consolidated practices could actually slow growth by revenue because larger customers demand volume discounts. Phreesia manages this by focusing on growth in customer count and transaction volume rather than price per seat, betting that as its platform becomes indispensable it can steadily raise fees.
Another constraint is regulatory change. Healthcare regulation in America is volatile. Insurance rules shift. Privacy rules shift. States regulate telehealth differently. Phreesia must keep its compliance systems current, which costs money and occasionally forces features to change. Any major regulatory rewrite could reduce the value of features practices rely on, forcing Phreesia to rebuild parts of its platform at cost to itself or at cost to customers who upgrade to comply.
The payments integration risk
Payment processing is the faster-growing part of Phreesia’s business by percentage, which makes it strategically important but also strategically vulnerable. A practice could theoretically use Phreesia for patient intake and scheduling but switch to a different payment processor if another vendor offers better rates. Conversely, regulations around payment processing, healthcare data security, and patient privacy could tighten, raising Phreesia’s compliance costs.
The company is also exposed to the overall volume of out-of-pocket patient payments. If the healthcare system shifts—if more people have insurance with low out-of-pocket costs, or if copays disappear—the transaction fee business shrinks. Phreesia cannot control that. It can only build tools that make payment collection frictionless and hope the underlying economics keep driving out-of-pocket volume.
How a reader would research Phreesia
Start with Phreesia’s annual 10-K filing (SEC CIK 0001412408), which breaks revenue by subscription, payment processing, and network solutions. Watch the customer additions each quarter and the net revenue retention—how much existing customers are expanding their spending. The quarterly earnings calls are where management reveals the real story: are large hospital systems accelerating their adoption? Are they negotiating harder on price? How much of new payment volume comes from the company winning share versus from the market simply growing?
Key metrics to track: customer count growth, average revenue per customer, transaction volume, gross margin on each business stream, and operating leverage—whether Phreesia is moving toward profitability. The company’s scale across four thousand practices means it is less vulnerable to losing a single customer, but it is also large enough that any slowdown in healthcare activity would ripple through results immediately. As with any investment, there is no recommendation here—only a map of how the business works and where its leverage and vulnerabilities lie.